337 related articles for article (PubMed ID: 30017302)
1. Multiple solid pancreatic lesions: Prevalence and features of non-malignancies on dynamic enhanced CT.
Zhu L; Dai MH; Wang ST; Jin ZY; Wang Q; Denecke T; Hamm B; Xue HD
Eur J Radiol; 2018 Aug; 105():8-14. PubMed ID: 30017302
[TBL] [Abstract][Full Text] [Related]
2. Diffuse Involvement of Pancreas is not Always Autoimmune Pancreatitis.
He M; Wang X; Xu J; Li J; Chang X; Zins M; Jin Z; Xue H
Acad Radiol; 2022 Oct; 29(10):1523-1531. PubMed ID: 35279380
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic neuroendocrine tumors containing areas of iso- or hypoattenuation in dynamic contrast-enhanced computed tomography: Spectrum of imaging findings and pathological grading.
Hyodo R; Suzuki K; Ogawa H; Komada T; Naganawa S
Eur J Radiol; 2015 Nov; 84(11):2103-9. PubMed ID: 26321494
[TBL] [Abstract][Full Text] [Related]
4. Comparison between neuroendocrine carcinomas and well-differentiated neuroendocrine tumors of the pancreas using dynamic enhanced CT.
Park HJ; Kim HJ; Kim KW; Kim SY; Choi SH; You MW; Hwang HS; Hong SM
Eur Radiol; 2020 Sep; 30(9):4772-4782. PubMed ID: 32346794
[TBL] [Abstract][Full Text] [Related]
5. Imaging mimics of pancreatic ductal adenocarcinoma.
Gandhi NS; Feldman MK; Le O; Morris-Stiff G
Abdom Radiol (NY); 2018 Feb; 43(2):273-284. PubMed ID: 29038855
[TBL] [Abstract][Full Text] [Related]
6. CT Density in the Pancreas is a Promising Imaging Predictor for Pancreatic Ductal Adenocarcinoma.
Fukuda Y; Yamada D; Eguchi H; Hata T; Iwagami Y; Noda T; Asaoka T; Kawamoto K; Gotoh K; Kobayashi S; Takeda Y; Tanemura M; Mori M; Doki Y
Ann Surg Oncol; 2017 Sep; 24(9):2762-2769. PubMed ID: 28634666
[TBL] [Abstract][Full Text] [Related]
7. Contrast-enhanced harmonic endoscopic ultrasound in solid lesions of the pancreas: results of a pilot study.
Napoleon B; Alvarez-Sanchez MV; Gincoul R; Pujol B; Lefort C; Lepilliez V; Labadie M; Souquet JC; Queneau PE; Scoazec JY; Chayvialle JA; Ponchon T
Endoscopy; 2010 Jul; 42(7):564-70. PubMed ID: 20593334
[TBL] [Abstract][Full Text] [Related]
8. Use of MDCT to Differentiate Autoimmune Pancreatitis From Ductal Adenocarcinoma and Interstitial Pancreatitis.
Lee-Felker SA; Felker ER; Kadell B; Farrell J; Raman SS; Sayre J; Lu DS
AJR Am J Roentgenol; 2015 Jul; 205(1):2-9. PubMed ID: 26102377
[TBL] [Abstract][Full Text] [Related]
9. Differentiation of hypovascular pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinoma using contrast-enhanced computed tomography.
Ren S; Chen X; Wang Z; Zhao R; Wang J; Cui W; Wang Z
PLoS One; 2019; 14(2):e0211566. PubMed ID: 30707733
[TBL] [Abstract][Full Text] [Related]
10. Assessment of main pancreatic duct cutoff with dilatation, but without visible pancreatic focal lesion on MDCT: a novel diagnostic approach for malignant stricture using a CT-based nomogram.
Lim CY; Min JH; Hwang JA; Choi SY; Ko SE
Eur Radiol; 2022 Dec; 32(12):8285-8295. PubMed ID: 35726102
[TBL] [Abstract][Full Text] [Related]
11. Comparison of diagnostic performance between CT and MRI in differentiating non-diffuse-type autoimmune pancreatitis from pancreatic ductal adenocarcinoma.
Lee S; Kim JH; Kim SY; Byun JH; Kim HJ; Kim MH; Lee MG; Lee SS
Eur Radiol; 2018 Dec; 28(12):5267-5274. PubMed ID: 29948075
[TBL] [Abstract][Full Text] [Related]
12. 3 T MR perfusion of solid pancreatic lesions using dynamic contrast-enhanced DISCO sequence: Usefulness of qualitative and quantitative analyses in a pilot study.
Donati F; Boraschi P; Cervelli R; Pacciardi F; Lombardo C; Boggi U; Falaschi F; Caramella D
Magn Reson Imaging; 2019 Jun; 59():105-113. PubMed ID: 30878601
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic neuroendocrine tumors: Correlation between the contrast-enhanced computed tomography features and the pathological tumor grade.
Takumi K; Fukukura Y; Higashi M; Ideue J; Umanodan T; Hakamada H; Kanetsuki I; Yoshiura T
Eur J Radiol; 2015 Aug; 84(8):1436-1443. PubMed ID: 26022520
[TBL] [Abstract][Full Text] [Related]
14. Dual-phase CT of autoimmune pancreatitis: a multireader study.
Takahashi N; Fletcher JG; Fidler JL; Hough DM; Kawashima A; Chari ST
AJR Am J Roentgenol; 2008 Feb; 190(2):280-6. PubMed ID: 18212210
[TBL] [Abstract][Full Text] [Related]
15. Impact of F18-fluorodeoxyglycose positron emission tomography/computed tomography on the management of resectable pancreatic tumours.
Yao J; Gan G; Farlow D; Laurence JM; Hollands M; Richardson A; Pleass HC; Lam VW
ANZ J Surg; 2012 Mar; 82(3):140-4. PubMed ID: 22510123
[TBL] [Abstract][Full Text] [Related]
16. Morphologic patterns of autoimmune pancreatitis in CT and MRI.
Rehnitz C; Klauss M; Singer R; Ehehalt R; Werner J; Büchler MW; Kauczor HU; Grenacher L
Pancreatology; 2011; 11(2):240-51. PubMed ID: 21625195
[TBL] [Abstract][Full Text] [Related]
17. [Diagnosis and staging of pancreatic carcinoma: MRI versus multislice-CT -- a prospective study].
Grenacher L; Klauss M; Dukic L; Delorme S; Knaebel HP; Düx M; Kauczor HU; Büchler MW; Kauffmann GW; Richter GM
Rofo; 2004 Nov; 176(11):1624-33. PubMed ID: 15497081
[TBL] [Abstract][Full Text] [Related]
18. Small serotonin-producing neuroendocrine tumor of the pancreas associated with pancreatic duct obstruction.
Kawamoto S; Shi C; Hruban RH; Choti MA; Schulick RD; Fishman EK; Siegelman SS
AJR Am J Roentgenol; 2011 Sep; 197(3):W482-8. PubMed ID: 21862776
[TBL] [Abstract][Full Text] [Related]
19. Dynamic quantitative evaluation of contrast-enhanced endoscopic ultrasonography in the diagnosis of pancreatic diseases.
Matsubara H; Itoh A; Kawashima H; Kasugai T; Ohno E; Ishikawa T; Itoh Y; Nakamura Y; Hiramatsu T; Nakamura M; Miyahara R; Ohmiya N; Ishigami M; Katano Y; Goto H; Hirooka Y
Pancreas; 2011 Oct; 40(7):1073-9. PubMed ID: 21633317
[TBL] [Abstract][Full Text] [Related]
20. Differentiation between non-hypervascular pancreatic neuroendocrine tumors and mass-forming pancreatitis using contrast-enhanced computed tomography.
Wang Y; Chen X; Wang J; Cui W; Wang C; Chen X; Wang Z
Acta Radiol; 2021 Feb; 62(2):190-197. PubMed ID: 32375515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
